Eastwood Bio-Medical Canada Inc. EBM.V
TSX
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 586.00K | 570.00K | 518.20K | 559.50K | 426.50K |
| Total Other Revenue | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Revenue | 586.00K | 570.00K | 518.20K | 559.50K | 426.50K |
| Cost of Revenue | 174.90K | 154.40K | 160.70K | 165.20K | 154.30K |
| Gross Profit | 411.10K | 415.60K | 357.50K | 394.30K | 272.20K |
| SG&A Expenses | 517.60K | 527.50K | 540.80K | 552.50K | 467.70K |
| Depreciation & Amortization | 22.60K | 15.10K | 7.50K | 31.60K | 51.80K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 715.00K | 697.00K | 709.00K | 749.30K | 673.80K |
| Operating Income | -129.00K | -127.00K | -190.80K | -189.80K | -247.40K |
| Income Before Tax | -167.10K | -160.80K | -222.80K | -236.90K | -295.70K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.17 | -0.16 | -0.22 | -0.24 | -0.30 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -167.10K | -160.80K | -222.80K | -236.90K | -295.70K |
| EBIT | -129.00K | -127.00K | -190.80K | -189.80K | -247.40K |
| EBITDA | -106.40K | -111.90K | -183.30K | -158.20K | -195.50K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 275.54M | 275.54M | 275.54M | 275.54M | 275.54M |
| Average Diluted Shares Outstanding | 275.54M | 275.54M | 275.54M | 275.54M | 275.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |